Alnylam Pharmaceuticals' PIPE Round

Alnylam Pharmaceuticals raised a round of funding on October 05, 2005. Investors include Novartis Venture Funds.

Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company believes that are many new therapeutic frontiers fo…

Articles about Alnylam Pharmaceuticals' PIPE Round: